Sanbio Company Limited Stock Short Ratio
| SNBIF Stock | USD 3.85 0.00 0.00% |
SanBio Company Limited fundamentals help investors to digest information that contributes to SanBio Company's financial success or failures. It also enables traders to predict the movement of SanBio OTC Stock. The fundamental analysis module provides a way to measure SanBio Company's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SanBio Company otc stock.
SanBio |
SanBio Company Limited OTC Stock Short Ratio Analysis
SanBio Company's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, SanBio Company Limited has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
SanBio Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SanBio Company's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of SanBio Company could also be used in its relative valuation, which is a method of valuing SanBio Company by comparing valuation metrics of similar companies.SanBio Company is currently under evaluation in short ratio category among its peers.
SanBio Fundamentals
| Return On Equity | -1.19 | |||
| Return On Asset | -0.74 | |||
| Current Valuation | 306.98 M | |||
| Shares Outstanding | 61.51 M | |||
| Shares Owned By Insiders | 35.76 % | |||
| Shares Owned By Institutions | 4.88 % | |||
| Price To Earning | (31.91) X | |||
| Price To Book | 11.63 X | |||
| Gross Profit | 447 M | |||
| EBITDA | (4.38 B) | |||
| Net Income | (4.68 B) | |||
| Cash And Equivalents | 8.34 B | |||
| Cash Per Share | 139.84 X | |||
| Total Debt | 2.01 B | |||
| Debt To Equity | 0.58 % | |||
| Current Ratio | 5.45 X | |||
| Book Value Per Share | 27.98 X | |||
| Cash Flow From Operations | (6.55 B) | |||
| Earnings Per Share | (0.59) X | |||
| Number Of Employees | 89 | |||
| Beta | 0.25 | |||
| Market Capitalization | 338.28 M | |||
| Total Asset | 5.51 B | |||
| Retained Earnings | (6.67 B) | |||
| Working Capital | 5.91 B | |||
| Current Asset | 6.71 B | |||
| Current Liabilities | 807 M | |||
| Z Score | -0.2 | |||
| Net Asset | 5.51 B |
About SanBio Company Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SanBio Company Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SanBio Company using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SanBio Company Limited based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in SanBio OTC Stock
SanBio Company financial ratios help investors to determine whether SanBio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SanBio with respect to the benefits of owning SanBio Company security.